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23 ABSTRACT
24 Absorption of glucose, via intestinal Na+/glucose cotransporter 1 (SGLT1), activates salt and 
25 water absorption and is an effective route for treating Escherichia coli (E. coli)-induced 
26 diarrhea.  Activity and expression of SGLT1 is regulated by sensing of sugars and 
27 artificial/natural sweeteners by the intestinal sweet receptor, T1R2-T1R3 expressed in 
28 enteroendocrine cells. Diarrhea, caused by the bacterial pathogen E-coli is the most common 
29 post-weaning clinical feature in rabbits, leading to mortality. We demonstrate here, that in 
30 rabbits with experimentally E-coli - induced diarrhea, inclusion of a supplement containing 
31 stevia leaf extract (SL) in the feed improves clinical signs of disease. We show that the rabbit 
32 intestine expresses T1R2-T1R3. Furthermore, intake of SL enhances activity and expression 
33 of SGLT1, and the capacity to absorb glucose. Thus, a natural plant extract sweetener can act 
34 as an effective feed additive for lessening the negative impact of enteric disease in animals.
35
36 Key words: Colibacillosis; Oral rehydration; Rabbit; SGLT1; Intestinal T1R2-T1R3
37
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39 INTRODUCTION
40 Na+/glucose co-transporter 1, SGLT1, is the major route for absorption of glucose across the 
41 intestinal brush border membrane. Absorption of glucose via SGLT1 activates electrolyte and 
42 water absorption. In humans, this strategy has been used in oral rehydration therapy, which is 
43 the safest and most effective remedy for treating life-threatening diarrhea induced by agents 
44 such as Vibrio cholerae and Escherichia coli.1,2 The condition is caused by toxic peptides 
45 produced by bacteria stimulating the conversion of guanosine 5′-triphosphate (GTP) to cyclic 
46 guanosine 5′-monophosphate (cGMP) by the enzyme guanylate cyclase. Increased 
47 intracellular cGMP inhibits intestinal fluid uptake, resulting in net fluid secretion and thus 
48 diarrhea. 
49 The gut epithelium can sense sugars and artificial sweeteners via the sweet receptor 
50 comprising of Taste family 1 Receptor 2 (T1R2) and 3 (T1R3) expressed on the luminal 
51 membrane of enteroendocrine cells (EEC).3,4 This results in secretion of gut hormones, 
52 glucagon-like peptide 1 (GLP-1), glucagon- like peptide 2 (GLP-2) and glucose-dependent 
53 insulinotropic peptide (GIP) from EEC. 5,6 GLP-2 upregulates SGLT1 activity and 
54 expression7,8 in neighboring absorptive enterocytes via a neuro-paracrine pathway. 6,9 GLP-2 
55 also increases villus height and intestinal barrier function10,11, thereby promoting gut health. 
56 These effects have also been reported in piglets;12 calves and ruminants.13 
57 The sweet taste receptor is similarly activated by natural, high-intensity sweeteners, such as 
58 stevia14 leading to increased expression and activity of SGLT1, providing the capacity for 
59 enhanced glucose (electrolyte and water) absorption. 
60 Rabbits are raised for a variety of commercial reasons. Their meat, wool and fur are valuable 
61 commodities, as is their nitrogen-rich manure and high protein milk. They are also very 
62 popular as household pets. Diarrhea is the most common post-weaning clinical feature in 
63 rabbits, leading to significant rates of mortality. With current trends aimed at decreasing the 
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64 use of antibiotics, feed additives that can improve rabbit health and performance in the face 
65 of disease is highly desirable. This is especially relevant in Europe, where antibiotic use in 
66 animal feed is already banned, and the use of natural alternatives, for disease prevention, is 
67 encouraged. Furthermore, in Europe the use of artificial sweeteners, used routinely in farm 
68 animal nutrition,12,13 is prohibited as supplements in rabbit feed. It is not known if a natural 
69 high-intensity sweetener such as stevia leaf extract (SL), which can be used in rabbit feed, 
70 will elicit similar effects as seen with artificial sweeteners in farm animals, assisting to 
71 prevent and ameliorate enteric diseases in rabbits.  
72 Here we show that when rabbits are challenged with colibacillosis, inclusion of a supplement 
73 containing SL in rabbit feed leads to significant reduction in diarrhea and bloat, improved 
74 health, and decreased mortality. Furthermore, we demonstrate that rabbit intestine expresses 
75 the intestinal sweet receptor T1R2-T1R3, and that inclusion of SL in the feed results in 
76 upregulation of SGLT1 activity, protein and mRNA abundance in the small intestine. Thus, a 
77 better understanding of the molecular mechanism underlying intestinal nutrient absorption 
78 provides a rational strategy for using a natural feed additive for alleviating enteric disorders 
79 and promoting health and well-being of animals.
80
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81 MATERIALS AND METHODS
82 Chemicals
83 SL supplement (containing 25% stevia leaf extract and 2% capsicum oleoresin (for 
84 concentration see below); TakTik Rabbit), was from Pancosma, Geneva, Switzerland. Zymo 
85 Total RNA isolation kit with on-column DNase 1 digestion, was from Cambridge Bioscience, 
86 Cambridge, UK. dT20 primers and superscript III reverse transcriptase was from Life 
87 Technologies, Paisley, UK and QIAquick PCR purification kit from Qiagen, Crawley, West 
88 Sussex, UK. Consensus primers for mammalian T1R2 and T1R3 were purchased from 
89 Eurogentec, Seraing, Belgium. Q5 Hot Start High-Fidelity DNA Polymerase was purchased 
90 from New England Biolabs, Hitchin, Herts, UK, and pGEM-T Easy vector from Promega, 
91 Southampton, UK. SYBR green JumpStart Taq ReadyMix, dithiothreitol, benzamidine, 
92 phenolmethylsulfonyl fluoride, Bio-Max Light Chemiluminescence Film, β-actin antibody 
93 (clone AC-15), D.P.X. neutral mounting medium, donkey serum, 10% neutral buffered 
94 formalin and Mayer’s Haemalum (3.3 mmol/L Mayer’s Haemalum-haematoxylin, 1 mmol/L 
95 sodium iodate, 0.42 mmol/L potassium alum) were purchased from Sigma-Aldrich, Poole, 
96 Dorset, UK. Bio-Rad protein assay solution and polyvinylidene difluoride (PVDF) membrane 
97 were from Bio-Rad Laboratories Ltd. Hemel Hempstead, UK. The antibody to SGLT1 was 
98 raised in rabbits (custom synthesis) to a recombinant peptide corresponding to amino acids 
99 554-640 of rabbit SGLT1 protein. Horseradish peroxidase-linked secondary antibodies were 
100 purchased from DAKO Ltd, Cambridge, UK. Immobilon Western Chemiluminescent HRP 
101 Substrate and cellulose acetate/nitrate filter were purchased from Millipore, Hertfordshire, 
102 UK and [U-14C]-D-glucose (10.6 GBq/mmol) from Perkin Elmer, Seer Green, Bucks, UK. 
103 Scintillation fluid (Optiphase HiSafe 3), was purchased from Fisher Scientific, UK and Eosin 
104 Y solution (1 % [w/v] eosin aqueous) was from HD Supplies, Buckingham, Bucks, UK. 
105 Chromogranin A antibody was from Abcam, Cambridge, UK. Antibodies to T1R2 and T1R3 
Page 5 of 37
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
6
106 are from Santa Cruz Biotechnology, INC., Heidelberg, Germany, and IgG Cy3- FITC-
107 conjugated secondary antibodies from Stratech Scientific, Newmarket, UK. 4ʹ,6-diaminido-2-
108 phenylindole (DAPI) was purchased from Vector Laboratories, Peterborough, UK.
109
110 Phase 1:
111 Animals, Treatments and Experimental condition. The animal experiment was conducted 
112 at the Talhouet Research Center (Saint Nolff, France). All animal procedures were approved 
113 by the Ethical Committee for Animal Experimentation of NEOVIA and by the Ministry of 
114 Higher Education, of Research and Innovation, France (experimental reference # 03835.03).  
115 Animal numbers were determined based on power calculations conducted using data from 
116 previous experiments performed in the same facility wherein colibacillosis challenge was 
117 used. Thirty-six day old Souche Hyplus PS59 rabbits (http://www.hypharm.fr; n = 300) were 
118 weaned, blocked by sex, litter origin and body weight, and assigned to one of four dietary 
119 treatments (n = 75/trt): un-supplemented diet or a diet supplemented with 50, 75, or 100 ppm 
120 of SL, containing a maximum of 3.3, 4.9 and 6.5 µM capsaicin). Animals were housed in 
121 cages (5 rabbits per cage) with ad libitum access to feed and water. Rabbit feed was 
122 formulated for a typical fattening ration containing 15.5% crude protein and ME of 22.9 
123 kcal/100 g feed. All feed was free of antibiotics and medications, including coccidiostats.  
124 The room was maintained at 19°C and was illuminated between 0700 and 1700 each day. All 
125 animals were monitored daily. 
126 On day 44 of age (day 0 of infection), all rabbits were orally inoculated with 5 x 106 CFU/mL 
127 of E. Coli O103 LY265 inoculum (INRA, Nouzilly, France; dose determined in preliminary 
128 experiments and validated in several separate experiments).  
129
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130 Measurements. Feed intake was measured daily per cage by weighing of refusals. Live 
131 weights of individual rabbits were measured on days -2, 5, 12, 19 and 26 post infection 
132 (corresponding to 42, 49, 56, 63, 70 d of age), and average daily gain (ADG) was calculated 
133 from individual body weights. Feed efficiency (G:F; gain/feed) was calculated per cage. 
134 Morbidities [visual signs of diarrhea and discoloration of feces, bloat (swollen stomach, dull 
135 fur, low energy), and mobility] were assessed daily by two technicians trained by a 
136 veterinarian. Morbidities were not quantified but were simply noted as present or absent 
137 based on subjective visual observation by both technicians. The same technicians performed 
138 the scoring throughout the study to avoid variation due to observer. Mortalities were also 
139 recorded daily; dead animals were removed from cages upon detection and visible clinical 
140 signs were noted. At the peak of mortality during clinical disease, a random selection of 
141 rabbits (n = 10) was necropsied to verify colibacillosis as the cause of death (via E. coli 
142 serotyping of intestinal content).    
143 The experiment ended on day 26 post infection (when animals were 70 d of age) and all 
144 remaining animals were euthanized by a trained technician. Average body weight at 70 d of 
145 age was multiplied by the number of animals alive to estimate production weight per 
146 treatment.    
147
148 Statistical Analysis. Data were analyzed by ANOVA using the SAS Mixed Procedure with a 
149 Dunnett’s adjustment for multiple comparisons and orthogonal contrasts to test for linearity.  
150 Treatment and time were fixed effects whereas sex and cage were treated as random effects.  
151 Statistical significance was set at p < 0.05.  
152
153 Phase 2:
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154 The experiments in Phase 2 were undertaken to understand the molecular mechanisms 
155 underlying the intestinal response of rabbits to SL.   
156 Animals, dietary trial, gut tissue sampling. The animal experiment was conducted at the 
157 Talhouet Research Center (Saint Nolff, France). All animal procedures were approved by the 
158 Ethical Committee for Animal Experimentation of NEOVIA and by the Ministry of Higher 
159 Education, of Research and Innovation, France (experimental reference # 03835.03). Animal 
160 numbers were determined using gut responses and variation associated with supplementation 
161 with artificial sweetener reported in published articles.6,12,13 Forty-two 60-day-old Souche 
162 Hyplus PS59 rabbits (http://www.hypharm.fr) were blocked by sex and body weight and 
163 assigned to one of two dietary treatments starting on day 61 of age (n = 21 rabbits/treatment): 
164 un-supplemented diet or a diet supplemented with 75 ppm SL (dose chosen based on 
165 responses observed in Phase 1). Animals were housed in cages (5 rabbits per cage) with ad 
166 libitum access to feed and water. Rabbit feed was formulated for a typical fattening ration 
167 containing 15.5% crude protein and ME of 22.9 kcal/100 g feed.  All feed was free of 
168 antibiotics and medications, including coccidiostats. The room was maintained at 19°C and 
169 was illuminated between 0700 and 1700 each day. After the 9-day treatment period (the 
170 period of 9 days was selected to cover the gut epithelial cell turnover that takes 4-5 days in 
171 the majority of species and was extended to 9 days due to travel delays for the researcher 
172 from the UK travelling to France for harvesting intestinal tissues) at 70 days of age (same 
173 slaughter age as phase 1), all rabbits were weighed and euthanized by intra-cardiac injection 
174 of Euthasol® after sedation starting at 9am. Intestinal tissues were removed, duodenal: 10 cm 
175 distal to the pyloric caeca, ileal: 10 cm proximal from the ileocecal valve, jejunal; at the mid-
176 point between the pyloric caeca and ileocecal valve. Tissue samples collected from 10 
177 rabbits/treatment (blocked by sex and body weight at slaughter), rinsed in ice cold saline and 
178 either placed into cryovials or wrapped in aluminum foil and frozen immediately in liquid 
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179 nitrogen or pinned to dental plastic and fixed in 10% neutral buffered formalin at 4°C. Fixed 
180 tissues were transferred to 20% sucrose in PBS after 24 h and stored at 4°C. Frozen tissues 
181 were stored at -80°C before shipping to the UK on dry ice, whilst fixed samples were shipped 
182 to the UK on wet ice, for subsequent analysis.
183
184 Cloning of rabbit T1R2 and T1R3. Total RNA was isolated from rabbit intestinal tissues 
185 using the Zymo Total RNA isolation kit with on-column DNase 1 digestion. RNA was 
186 quantified by UV spectrophotometry (assuming an OD260 value of 1 = 40 μg/mL) and 
187 integrity determined by agarose gel electrophoresis. Complementary DNA (cDNA) was 
188 prepared using oligo dT20 primers and superscript III reverse transcriptase, purified using 
189 QIAquick PCR purification kit and quantified by UV spectrophotometry (assuming an OD260 
190 value of 1 = 33 μg/mL). Consensus primers for mammalian T1R2 and T1R3 are listed in 
191 Table 1. Each PCR reaction mix contained 0.5 μmol/L of each forward and reverse primer, 
192 0.5 U of Q5 Hot Start High-Fidelity DNA Polymerase, and 25 ng template cDNA in a final 
193 volume of 25 μl. PCR cycling was carried out as follows: initial denaturation at 98°C for 1 
194 min, 25 cycles of denaturation at 98°C for 10 s, annealing for 10 s and extension at 72°C for 
195 30 s, followed by a final extension step at 72°C for 2 min. PCR amplicons were gel purified 
196 using 1% agarose gels, cloned into pGEM-T Easy vector and custom sequenced (Eurofins-
197 MWG, Ebersberg, Germany). Sequence alignments and amino acid translations were 
198 performed using commercial software (Vector NTI, Life Technologies).
199 The radial phylogram shown in Figure 7, depicting the phylogenetic relationship of rabbit 
200 T1R3 to various mammalian homologs, was constructed by neighbor-joining analysis15 of 
201 distance matrices generated using the PROTDIST program (Jones-Taylor-Thornton similarity 
202 model),16 as part of the phylogenetic inference package, PHYLIP.17
203
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204 Table 1. Primers used for PCR and qPCR. 
Primer name Accession No. sequence Tm / °C
RbACTB S NM_001101683 5'-CCTTCTACAACGAGCTGCGAG-3' 51.4
RbACTB AS NM_001101683 5'-GCCCTCGTAGATGGGTACTG-3' 49.9
RbPOLR2A S XM_017348893.1 5'-ACGCTGCTCTTCAACATCCA-3' 60
RbPOLR2A AS XM_017348893.1 5'-CCAGCGTAGTGGAAGGTGTT-3' 60
RbB2M S XM_008269078.2 CTAGTCTTGTTCCCCTGCCT 58.9
RbB2M AS XM_008269078.2 ATCAATCTGGGGCGGATGAAA 60
RbT1R2 S XM_017346518 5'-TCTGGAACGTCAGCTTCACC-3' 52.5
RbT1R2 AS XM_017346518 5'-GTGCTTCAGCATGGGGTAGT-3' 51.6
RbT1R3 S 5'-GCAAGTTCTTCAGCTTCTTCCT-3' 51.5
RbT1R3 AS 5'-TACATGTTCTCCAGGAGCTGC-3' 51.9 
RbSGLT1 S NM_001101692 5'-TGTCAAGGCTGGCTGTATCC-3' 51.4
RbSGLT1 AS NM_001101692 5'-CTCCTCTGGTTCCACGCAA-3' 51.3
205
206 Quantitative PCR. Relative mRNA expression in the intestine was determined by 
207 quantitative real-time PCR (qPCR). cDNA was prepared from total RNA as described above 
208 and diluted to 5 ng/µL. Primers to rabbit SGLT1, β-actin (ACTB), RNA polymerase II 
209 (POLR2A), and β-2-microglobulin (B2M) were designed using Primer-BLAST18 and 
210 purchased from Eurogentec (see Table 1). Each qPCR reaction consisted of 25 ng cDNA 
211 template, 1 X SYBR green JumpStart Taq ReadyMix and 900 nmol/L of each primer in a 
212 total volume of 25 µL. The PCR cycling consisted of initial denaturation at 95°C for 2 min 
213 followed by 45 cycles of 95°C for 15 s and 60°C for 1 min. Assays were performed in 
214 triplicate using a RotorGene 3000 (Qiagen) with relative abundance calculated using RG-
215 3000 comparative quantification software (Qiagen). Abundance of SGLT1 mRNA was 
216 normalized to the genomic mean of ACTB, POLR2A and B2M housekeeping genes, the 
217 expression of which did not change throughout the study. qPCR assays without the RT step 
218 were routinely employed as negative controls and showed no amplification. Melt curve 
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219 analysis showed no primer dimer formation in the assays. PCR amplicons were cloned into 
220 pGEM-T easy vectors and sequenced to confirm veracity. 
221
222 Preparation of Brush Border Membrane Vesicles. Brush border membrane vesicles 
223 (BBMV) were isolated from different regions of rabbit small intestinal tissues based on the 
224 procedure described by Shirazi-Beechey et al.,19 with modifications outlined by Rowell-
225 Schäfer et al.20 and Dyer et al.21 All steps were carried out at 4°C. Tissues were thawed in a 
226 buffer solution (100 mmol/L mannitol, 2 mmol/L HEPES/Tris pH 7.1 with protease 
227 inhibitors, 0.5 mmol/L dithiothreitol, 0.2 mmol/L benzamidine, and 0.2 mmol/L 
228 phenolmethylsulfonyl fluoride), cut into small pieces and vibrated for 1.5 min at speed 5 
229 using a FUNDAMIX vibro-mixer (DrM, Dr Mueller AG, Maennedorf, Switzerland), in order 
230 to free intestinal epithelial cells. The filtrate was then homogenized using a Polytron (Ystral, 
231 Reading, Berkshire, UK) for 20 s. Next, MgCl2 was added to a final concentration of 10 
232 mmol/L and the solution stirred on ice for 20 min. The suspension was then centrifuged for 
233 10 min at 3,000 x g (SS34 rotor, Sorvall, UK) and the resulting supernatant was spun for 30 
234 min at 30,000 x g. The pellet was suspended in buffer (100 mmol/L mannitol, 0.1 mmol/L 
235 MgSO4, and 20 mmol/L HEPES/Tris pH 7.1) and homogenized with 10 strokes of a Potter 
236 Elvehjem Teflon hand-held homogenizer before centrifuging for 30 min at 30,000 x g. The 
237 final pellet was re-suspended in an isotonic buffer solution (300 mmol/L mannitol, 0.1 
238 mmol/L MgSO4, and 20 mmol/L HEPES/Tris pH 7.4) and homogenized by passing through a 
239 27-gauge needle several times. The protein concentration in the BBMV was estimated by its 
240 ability to bind Coomassie blue according to the Bio-Rad assay technique. Porcine γ-globulin 
241 was used as the standard. Inclusion of protease inhibitors in the buffers is essential for 
242 avoiding SGLT1 protein degradation.
Page 11 of 37
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
12
243 In preparation for western blot analysis, aliquots of freshly prepared BBMV were diluted 
244 with sample buffer (62.5 mmol/L Tris/HCl pH 6.8, 10% [v/v] glycerol, 2% [w/v] SDS, 0.05% 
245 [v/v] β-mercaptoethanol, 0.05% [w/v] bromophenol blue) and stored at -20°C until use. The 
246 remaining BBMV were divided into aliquots and stored in liquid nitrogen or used 
247 immediately for glucose uptake studies. 
248
249 Western Blotting. The abundance of SGLT1 and β-actin proteins in the BBMV isolated 
250 from rabbit small intestine was determined by western blotting as described previously.12,21 
251 Protein components of BBMV (20 µg) were separated by sodium dodecyl sulfate (SDS)-
252 polyacrylamide gel electrophoresis on 8% (w/v) polyacrylamide mini gels, containing 0.1% 
253 (w/v) SDS, and electrotransferred to polyvinylidene difluoride (PVDF) membrane. The 
254 PVDF membranes were blocked for 1h at RT in PBS containing 0.5% (w/v) non-fat dried 
255 milk, and 0.05% (v/v) Tween-20 (PBS-TM). Incubation for 1 hour with the SGLT1 antibody 
256 diluted 1:1,000 in PBS-TM then followed. 
257 Immuno-reactive bands were detected by incubation for 1 h with affinity purified horseradish 
258 peroxidase-linked anti-rabbit secondary antibody diluted 1:2,000 in PBS-TM, and visualized 
259 using Immobilon Western Chemiluminescent HRP Substrate and Bio-Max Light 
260 Chemiluminescence Film. The intensity of the immunoreactive bands was quantified using 
261 scanning densitometry (Total Lab, Newcastle-upon-Tyne, UK).
262 The PVDF membranes were stripped by 3 x 10 min washes in 137 mmol/L NaCl, 20 mmol/L 
263 glycine/HCl (pH 2.5) and then re-probed with a monoclonal antibody to β-actin used as a 
264 loading control. Blocking solution consisted of 0.1% (v/v) Triton X-100 and 0.1 mmol/L 
265 EDTA in PBS (PBS-TE) and 5% (w/v) skimmed milk powder. PBS-TE was used for the 
266 incubation and washing buffers. Horseradish peroxidase-linked anti-mouse secondary 
267 antibody diluted 1:2,000 in PBS-TE was used, and visualized as above.
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269 Measurement of Na+-dependent glucose uptake. Na+-dependent glucose uptake into rabbit 
270 intestinal BBMV was measured as described.12,19 The uptake of D-glucose was initiated by 
271 the addition of 100 µL of incubation medium (100 mmol/L NaSCN [or KSCN], 100 mmol/L 
272 mannitol, 20 mmol/L HEPES/Tris [pH 7.4], 0.1 mmol/L MgSO4, 0.02% [w/v] NaN3 and 0.1 
273 mmol/L [U-14C]-D-glucose [10.6 GBq/mmol,]) to BBMV (100 µg protein) at 37°C. The 
274 reaction was stopped after 3 s by the addition of 1 mL of ice-cold stop buffer (150 mmol/L 
275 KCl 20 mmol/L HEPES/Tris [pH 7.4], 0.1 mmol/L MgSO4, 0.02% [w/v] NaN3 and 0.1 
276 mmol/L phlorizin). Aliquots (0.9 mL) of the reaction mixture were removed and filtered 
277 under vacuum through a 0.22 µm pore cellulose acetate/nitrate filter. The filter was washed 
278 with 5 x 1 mL of ice-cold stop buffer, placed in a vial containing 4 mL of scintillation fluid 
279 and the radioactivity retained on the filter measured using a Tri-Carb 2910TR Liquid 
280 Scintillation Analyzer (PerkinElmer, Bucks, UK). All uptakes were measured in duplicate. 
281
282 Morphometry. Rabbit small intestinal tissue was fixed and cryo-protected before embedded 
283 in OCT (Fisher Scientific, UK), frozen at -20°C and then kept at -80°C until use. Tissue 
284 blocks were sectioned (10 µm) on a cryostat (Leica, CM 1900UV-1-1, Milton Keynes, 
285 Buckinghamshire, UK) and thaw-mounted onto polylysine-coated slides. Morphometric 
286 analysis was performed as described previously.12 The sections were exposed to tap water for 
287 1 min, transferred to Mayer’s Haemalum for 1 min and washed gently with running tap water 
288 for 5 min. They were stained with eosin Y solution for 30 s and subsequently dehydrated by 
289 stepwise washing in 70% ethanol (v/v) for 2 x 1-min, absolute ethanol for 2 x 1-min, and 
290 xylene for 3 x 1-min, before mounting with D.P.X. neutral mounting medium.
291 Digital images were captured with an Eclipse E400 microscope and DXM 1200 digital 
292 camera (Nikon, Kingston upon Thames, Surrey, UK), analyzed using ImageJ software 
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293 (Wayne Rasband, US National Institutes of Health, Bethesda, MD) and calibrated using a 100 
294 μm gradient slide. The crypt depth and the villus height were measured as the average 
295 distance from crypt base to crypt-villus junction and villus base to villus tip, respectively. The 
296 villus height and the crypt depth measurements were taken from an average of sixteen well 
297 oriented crypt-villus units. A minimum of three images were captured per section with a 
298 minimum of 8 sections prepared per animal, with each section being 5 sections apart within 
299 the block. All images were captured under the same conditions with care taken to ensure that 
300 the same villus was not counted twice. 
301
302 Immunohistochemistry. Immunohistochemistry was performed as previously described.22 
303 Tissue sections (10 µm thick, on polylysine coated slides) were washed five times for 5 minutes 
304 each in PBS. Slides were then incubated for 1 hour in blocking solution (10% (v/v) donkey 
305 serum in PBS) at room temperature in a humidified chamber. Subsequently, sections were 
306 incubated overnight at 4°C with primary polyclonal antibodies. The antibody to Chromogranin 
307 A (1:100), T1R2 (1:200) and T1R3 (1:200). The T1R2 antibody was raised against a peptide 
308 corresponding to residues 426-570 of mouse T1R2 that shares 66% homology with rabbit 
309 T1R2, and T1R3 to a peptide corresponding to the c-terminus of human T1R3. Cloned rabbit 
310 T1R3 shares 69% homology to human T1R3. After incubation of sections with primary 
311 antibodies, slides were washed five times for 5 minutes each in PBS and subsequently stained 
312 for 1 hour at room temperature using a 1:500 dilution of Cyanine 3 (Cy3)- or Fluorescein 
313 isothiocyanate (FITC)-conjugated anti-goat, anti-rabbit and anti-mouse IgG secondary 
314 antibodies. The composition of the buffer containing antibodies (primary or secondary) was 
315 2.5% (v/v) donkey serum, 0.25% (w/v) NaN3, and 0.2% (v/v) Triton X-100 in PBS. Finally, 
316 slides were washed five times for 5 minutes each in PBS and then mounted with Vectashield 
317 Hard Set Mounting Medium with (DAPI). Immunofluorescent labeling of Chromogranin A, 
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318 T1R2 and T1R3 proteins was visualized using an epifluorescence microscope (Nikon, 
319 Kingston-Upon-Thames, UK), and images were captured with a digital camera (model C4742-
320 96-12G04, Hamamatsu Photonics, Welwyn Garden City, UK). Omission of primary antibodies 
321 was routinely used as the control. 
322
323 Statistical Analysis. All parameters were tested for normality by the Shapiro–Wilk test. For 
324 comparison of SGLT1 expression in intestinal tissues and measurements of crypt-depth/villus 
325 height in intestinal tissues a Student’s two-tailed t-test was used to determine statistical 
326 significance (GraphPad Prism 5, GraphPad Software Inc., La Jolla, CA). The level of 
327 statistical significance was set at p < 0.05. 
328
329
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330 RESULTS
331 Phase 1 studies
332 Assessment of rabbit performance. Rabbit daily weight gain, feed intake, and gain to feed 
333 ratios are presented in Figure 1. E-coli inoculation markedly decreased daily weight gain (p < 
334 0.001; Figure 1A) across all dietary treatments until surviving animals had recovered by day 
335 19 post infection (63 days of age).  There was no effect of dietary supplementation on daily 
336 weight gain (p > 0.70; Figure 1A). Feed intake was not affected by inoculation Figure 1B).  
337 There was a trend for an effect of dietary treatment (p < 0.10) such that the animals 
338 supplemented with 75 ppm SL consumed more feed in the middle of the clinical phase of 
339 disease (day 12 post infection; 56 days of age; Figure 1B). Inoculation markedly decreased 
340 efficiency of growth (p < 0.001; Figure 1C) and this was not influenced by dietary treatment 
341 (p > 0.50). None of the groups recovered to pre-inoculation feed efficiency for the duration of 
342 the study.     
343
344 Mortality and morbidities. Rabbit rates of mortality are presented in Figure 2. The 
345 colibacillosis challenge had a strong effect and elicited a marked increase in mortality rate (p 
346 < 0.001; Figure 2A), with peak levels reached on day 19 post infection (63 d of age). There 
347 was no effect of dietary treatment on percent rate of mortality (p > 0.30); however, the 75 
348 ppm SL group had nearly half the mortality rate of the control group. Cumulative death was 
349 increased by inoculation (p < 0.001; Figure 2B), and the number of dead animals tended to 
350 decrease with doses of 50 and 75 ppm (p < 0.20; Figure 2B). The average body weight on 
351 day 26 post infection (70 d of age) was multiplied by the number of animals alive on that day 
352 to give production weights of 112.5, 119.2, 121.2, and 111.9 g for animals supplemented with 
353 0, 50, 75, and 100 ppm SL, respectively.
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354 Morbidities (diarrhea and bloat) are presented in Figure 3. The majority of morbidities 
355 observed were diarrhea, and this was increased with inoculation (p < 0.001; Figure 3A). All 
356 animals reached pre-inoculation levels by day 26 post infection (70 d of age) and there was 
357 no effect of dietary treatment on percent morbidities (p > 0.40; Figure 3A). The cumulative 
358 number of morbidities also increased with inoculation (p < 0.001; Figure 3B) and there was a 
359 significant treatment effect characterized by fewer morbid animals in the 50 and 75 ppm SL 
360 groups, compared to control animals (p < 0.01; Figure 3B). 
361
362 Phase 2 studies
363 Rabbit SGLT1 expression and activity is enhanced by feed supplementation with the 
364 natural high-intensity sweetener, stevia leaf. SGLT1 expression and activity was 
365 determined along the length of the small intestine in rabbits, fed a diet supplemented with SL 
366 and the same diet without SL (control diet). Irrespective of diets, levels of SGLT1 mRNA, 
367 protein and function were highest in the duodenum>jejunum>ileum. There was a 1.4- (p < 
368 0.05) and 1.3-fold (p < 0.001) increase in SGLT1 mRNA abundance in the duodenum and 
369 jejunum of rabbits fed a diet supplemented with SL compared to control diet (Figure 4A).  
370 SGLT1 protein abundance measured in BBMV increased by 1.6- (p < 0.001) and 1.6-fold (p 
371 < 0.001) in the duodenum and jejunum of rabbits fed a diet supplemented with SL compared 
372 to control (Figure 4B). This was matched by 1.8- (p < 0.050) and 1.7-fold (p < 0.050) 
373 increase in the initial rates of D-glucose transport into BBMV in the duodenum and jejunum 
374 of rabbits fed a diet supplemented with SL compared to the control diet (Figure 4C). No 
375 increases in either SGLT1 mRNA, protein abundance, or the initial rate of D-glucose 
376 transport into BBMV were observed in the ileum of rabbits fed a diet supplemented with SL, 
377 compared to control diet (Figure 4). There was a 1.4- (p < 0.0010) and 1.3-fold (p < 0.0010) 
378 increase in villus height in the duodenum and jejunum of SL fed rabbits compared to controls 
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379 (Figure 5). There was no difference in the average villus heights of control and SL fed rabbits 
380 in the ileum. 
381
382 Expression of T1R2 and T1R3 in the rabbit intestine. For rabbit T1R2, PCR primers were 
383 designed against the predicted mRNA sequence available on the National Center for 
384 Biotechnology Information (NCBI) non-redundant nucleotide database. PCR amplicons using 
385 rabbit jejunal cDNA and the designed T1R2 primers resulted in a 152 bp amplicon, which 
386 was found to be a 100% match to the predicted NCBI sequence, revealing that rabbit intestine 
387 expresses T1R2 (Figure 6). An alignment of the full-length rabbit T1R2 mRNA sequence 
388 showed 55.3% homology with cow, pig, human, mouse and rat T1R2.
389
390 As no sequence information on rabbit T1R3 was available from the current release of the 
391 rabbit genome (NCBI OryCun2.0 Annotation Release 102), it was necessary to clone rabbit 
392 T1R3 to obtain mRNA sequence data and verify its expression in the rabbit intestine. PCR 
393 amplification using rabbit jejunal cDNA and consensus mammalian T1R3 primers resulted in 
394 a 1221 bp fragment that was screened against the National Center for Biotechnology 
395 Information (NCBI) non-redundant nucleotide database, via BlastN, 23 identifying the 
396 amplified sequence as being homologous to T1R3 in many other mammalian species. The 
397 mRNA fragment was subsequently translated to produce a sequence of 407 amino acids 
398 (corresponding to residues 116-515 of human T1R3). Phylogenetic analysis was performed to 
399 construct a radial phylogram depicting the relationship of rabbit T1R3 to homologs in various 
400 other mammalian species for which sequence information was available (Figure 7). The 
401 NCBI accession number for the mRNA sequence of rabbit T1R3 is MK182098.  
402
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403 Immunofluorescence detection for the sweet receptor subunits, T1R2 and T1R3, as well as 
404 the classical marker for enteroendocrine cells, chromogranin A, was performed on frozen 
405 tissue sections of rabbit duodenum and jejunum. As shown in figure 8, T1R2 and T1R3 were 
406 co-expressed in the same cell (Figure 8A). Furthermore, both T1R2 and T1R3 were co-
407 expressed with chromogranin A, confirming receptor subunits expression in the 
408 enteroendocrine cell (Figure 8B). 
409
410 DISCUSSION
411 Feeding of low-level antibiotics has been a routine procedure for controlling enteric 
412 pathogens, preventing disease, improving health and growth, in particular in post weaning- 
413 animals.24 However, increasing antibiotic resistance and rising consumer concern over 
414 prophylactic antibiotic use in animal production has led to a concerted search for effective 
415 alternatives.  In humans, oral rehydration therapy, which relies on absorption of glucose via 
416 SGLT1, activating electrolyte and water absorption is a safe and effective method for the 
417 treatment of E-coli- and Vibrio cholerae- induced diarrhea.1 The discovery that sensing of 
418 sugars and sweeteners by the gut-expressed sweet receptor T1R2-T1R3 enhances the 
419 expression and activity of SGLT1,4 has allowed the design of novel strategies for animal 
420 nutrition that use artificial sweeteners to combat diarrheal and enteric diseases.25
421 E. coli- induced diarrhea is endemic in rabbits and results in high rates of morbidity and 
422 mortality. In the EU, artificial sweeteners are not permitted to be used in rabbit feed.
423 We hypothesized that rabbit intestine expresses the intestinal sweet receptor T1R2-T1R3, and 
424 that a natural high intensity sweetener (stevia) activates the receptor leading to SGLT1 
425 upregulation improving E-coli–induced enteric disorders. The supplement used in this study 
426 contained a small amount (2%) of capsicum oleoresin (~ 4.9 µM capsaicin) shown to 
427 influence immunity. However, using heterologous expression of rabbit T1R2-T1R3 we have 
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428 determined that capsaicin does not activate rabbit T1R2-T1R3. In contrast, stevia leaf extract 
429 (SL) activates the receptor in a dose-dependent manner (unpublished data, paper in 
430 preparation). 
431 Work in the laboratory of Tavakkkolizadeh and colleagues26,27 have questioned the role of 
432 vagal afferent fibres in SGLT1 regulation  by vagotomy and de-afferentation with  1 mg 
433 capsacin applied per animal. They have concluded that vagal de-afferention abolishes SGLT1 
434 upregulation in response to increased luminal glucose. They have further proposed that the 
435 specific involvement of vagal afferent fibres and enteric nervous system in glucose-sensing 
436 initiated regulatory pathway controlling SGLT1 expression remains unclear.27  
437 Bates, Sharkey and Meddings 1998,28 have shown that guinea pigs treated with vehicle, and 
438 thus having intact vagal afferent were able to increase the ability to enhance intestinal glucose 
439 transport when switched from a low- to a high-carbohydrate containg diet. In contrast, 
440 animals that received 32.8 mM solution of capsaicin demonstrated no adaptation to 
441 alterations in dietary composition.28 Interestingly Nassar et al. 1995,29 have shown that 
442 capsaicin (160 and 800 µM) reduces significantly intestinal alanine absorption when perfused 
443 either intraluminally or applied topically to the vagus nerve, concluding the involvement of 
444 vagal capsaicin sensitive primary afferent fibres in this inhibitory mechanism.29 Thus, it 
445 appears that vagal de-afferentiation may have a generalized effect on inhibiting a range of 
446 intestinal nutrient absorptive processes.
447 The results of studies carried out by Strearns et al., 2010 and Bates et al., 1998 are in contrast 
448 to this study. In our study, rabbits fed diets that included stevia and capcaicin (maximum 
449 capsaicin concentration, 4.9 µM) were able to upregulate glucose transporter 
450 expression/activity compared to those fed the same diet without capsaicin.
451 We have shown recently that electric field stimulation of an isolated segment of the intestine 
452 results in 2-3 fold increase in SGLT1 upregulation.6 This increase is abolished in presence of 
Page 20 of 37
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
21
453 the nerve blocking agent tetrotodoxin, indicating the involvement of enteric nervous system 
454 in the regulatory pathway. We used this strategy because sensing of glucose or artificial 
455 sweeteners via T1R2-T1R3, expressed in enteroendocine cells, stimulates GLP-2 release, and 
456 GLP-2 via binding to its receptor (GLP-2R) present in enteic neurons induces an action 
457 potential.30 We showed that electric field stimulation of enteric neurons, induces a neural 
458 response leading to secretion of specific neropeptides that upregualte SGLT1 expression in 
459 the neighbouring absorptive enterocyte, by enhancing half-life of SGLT1 mRNA and thus 
460 increased in SGLT1 protein abundance6. Our studies strongly supports the involvement of 
461 enteric neurons in a glucose-sensing initiated pathway regulating SGLT1 expression.6 
462 Addititional studies are required to address if there is a specific involvement of vagus nerve 
463 in SGLT1 regulatory pathway.
464 In this study we determined the effect of supplementation of feed with an additive containing 
465 SL on rabbit intestinal SGLT1 expression, as sweeteners are known to enhance Na+-
466 dependent glucose absorption in other mammalian species.4,12,13 Since the regulatory pathway 
467 controlling SGLT1 expression/function is initiated by activation of the gut-expressed sweet 
468 receptor T1R2-T1R3, we aimed to identify if these receptor subunits were expressed in the 
469 rabbit intestine. The gene for rabbit T1R2 has previously been identified from the rabbit 
470 genome sequence, located on chromosome 13 (NCBI OryCun2.0 Annotation Release 102); 
471 however, no information was available for rabbit T1R3. To determine expression of T1R2 
472 and T1R3 in rabbit intestine, a PCR based strategy was used to demonstrate that rabbit 
473 intestine does indeed express both receptor subunits T1R2 and T1R3 at mRNA level.  
474 Moreover, by immunohistochemistry we showed that T1R2, T1R3 proteins are co-expressed 
475 in the same intestinal enteroendocrine cell. Furthermore, SGLT1 mRNA, protein abundance 
476 and glucose transport function were increased ~2-fold by dietary inclusion of SL, providing a 
477 higher capacity for the rabbit intestine to absorb glucose, electrolyte and water. There was 
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478 also 1.4-fold increase in villus height in rabbits consuming SL, likely due to GLP-2 action.13 
479 In these dietary studies, we maintained rabbits on diets with and without SL for 9 days. We 
480 have shown SGLT1 upregulation, with a similar increase in magnitude after 1 day or 5 day in 
481 response to increased dietary carbohydrates or sweeteners4,6, indicating that increase in 
482 SGLT1 expression occurs in existing absorptive enterocytes.6,7 However, since this was the 
483 first time that we were assessing potential SGLT1 upregulation in response to inclusion of a 
484 natural sweetener in the feed of rabbits, we selected a 5-day dietary trial in order to cover 
485 intestinal epithelial cell turnover that takes 4-5 days in the majority of species. This period 
486 was extended to 9 days because of the researcher travel delays from the UK to France for 
487 harvesting rabbit intestinal tissues. 
488 We also assessed the effect of supplementation of rabbit feed with SL on relieving E. coli-
489 induced enteric disorders and observed that inclusion of SL in the feed decreases morbidity 
490 associated with disease. Although we did not observe a linear dose response, there was a 
491 clear trend for improved morbidities at the two lower doses. Such hormetic responses to 
492 plant-based supplements are common; very low doses are beneficial whereas higher doses are 
493 non-specific and detrimental31. To our knowledge this is the first report evaluating the effect 
494 of a natural artificial sweetener on rabbit health and performance, and the associated 
495 molecular mechanisms.  
496 The E. coli challenge elicited a marked impact on performance, characterized by blunted feed 
497 intake, decreased daily gain, and efficiency of growth. These are classical signs of infection 
498 that not only lead to stressed animals but have a devastating economic impact in rabbit 
499 production. The use of artificial sweetener to prevent decreased performance during stress 
500 has been explored previously. For example, Sterk et al.32 reported that supplementation of 
501 weanling piglets with artificial sweetener prevented the decrease in feed intake around 
502 weaning. Similar observations have been made for receiving feedlot cattle with respect to 
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503 both feed intake33 and daily weight gain.34 Whilst in this study the inclusion of SL in the feed 
504 had some impact on feed intake, the major effect is at the gut level where activation of gut-
505 expressed T1R2-T1R3 by sweeteners results in the secretion of GLP-2, a gut hormone that 
506 can alter appetite,35 and also the intestinal uptake of glucose leading to improved efficiency 
507 of growth.6 It has indeed been shown that artificial sweeteners directly introduced into the 
508 lumen of the intestine, bypassing the oral cavity, lead to an increase in expression of SGLT1 
509 and higher rates of intestinal glucose absorption.27
510 It was noteworthy that the E. coli challenge in this study was quite severe, with mortality rate 
511 peaking at nearly 60% during the clinical trials in some groups. Despite the severity of the 
512 disease challenge, the supplement showed a trend for a positive effect on cumulative 
513 morbidities at the lower doses. This observation was consistent with those we made during 
514 our preliminary experiments to establish the optimal timing and dose of inoculation (data not 
515 shown). Previous work using an artificial high-intensity sweetener has revealed similar 
516 effects during enteric disease challenge,36 but this is the first report on the impact of a natural 
517 high-intensity sweetener for prevention of clinical signs of enteritis in rabbits. The positive 
518 impact of the supplement on morbidities, combined with the molecular responses we 
519 observed, are consistent with an increase in GLP-2 secretion which is known to be essential 
520 for gut repair after injury,25 and also an enhancement in nutrient absorption.6 In this scenario, 
521 the increased glucose, electrolyte and water absorption at the intestinal level likely decreased 
522 the clinical signs of disease associated with diarrhea, and the enteric lesions caused by the 
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646 Figure 1. Growth performance of rabbits supplemented with 0, 50, 75, or 100 ppm of an 
647 additive containing natural high-intensity sweetener (SL) and inoculated with Escherichia 
648 coli on day 44 of age (red arrow). Data presented are LS Means, with SEM indicated on each 
649 panel. A, daily weight gain; B, daily feed intake; C, gain:feed.  
650 Figure 2. Mortality of rabbits supplemented with 0, 50, 75, or 100 ppm of an additive 
651 containing natural high-intensity sweetener (SL) and inoculated with Escherichia coli on day 
652 44 of age (red arrow). A, percent mortality over time. B, total number of dead animals over 
653 time. Mortality was calculated by dividing the number of new deaths recorded at each time 
654 point by the number of animals alive at the previous time point, and then multiplying by 100.
655 Figure 3. Morbidity (diarrhea, abnormal feces, and/or bloat) of rabbits supplemented with 0, 
656 50, 75, or 100 ppm of an additive containing natural high-intensity sweetener (SL) and 
657 inoculated with Escherichia coli on day 44 of age (red arrow). A, percent morbidity over 
658 time. B, cumulative morbidity over time. * = p < 0.05; ** = p < 0.01
659 Figure 4. Expression and activity of SGLT1 in the intestine of control rabbits and in 
660 rabbits maintained on the same diet supplemented with SL. Brush border membrane 
661 vesicles (BBMV) and RNA were isolated from small intestinal tissues of rabbits fed either a 
662 control diet (C) or a diet supplemented with an additive containing natural high-intensity 
663 sweetener (SL). A: Level of SGLT1 mRNA abundance normalized to β-actin, RNA 
664 polymerase II and β-2-microglobulin mRNA. B: Expression of SGLT1 and β-actin proteins 
665 in BBMV isolated from the small intestine assessed by western blotting (left panel). 
666 Densitometric analysis of SGLT1 protein abundance normalized to β-actin (right panel). C: 
667 Initial rates of Na+-dependent [U14C]-D-glucose uptake into BBMV. Data were generated in 
668 triplicate. Results are shown as mean ± SEM; n = 7 animals. Statistically significant results 
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669 determined using a Student’s two-tailed t-test where * = p < 0.050; ** = p <0.010; *** = p 
670 <0.001.
671 Figure 5. Morphometric analysis of the rabbit intestine. A) Representative light 
672 micrographs of small intestinal tissues of control and natural high-intensity sweetener (SL) 
673 fed rabbits. Images were obtained at 4X magnification. B) Morphometric analyses of villus 
674 height and crypt depths are shown as histograms, in (µm) ± SEM. Control ( ), SL-fed ( ); n 
675 = 5 animals. Statistically significant results were determined using Student’s two-tailed t-test 
676 where ** = p < 0.010.   
677 Figure 6. Alignment of rabbit T1R2 mRNA sequence with the corresponding region of cow, 
678 pig, human, mouse and rat T1R2 (numbers in parentheses relate to initiating nucleotide).
679 Figure 7. Radial phylogram, derived from amino acid sequences, depicting the phylogenetic 
680 relationship of rabbit T1R3 to various mammalian homologs.  The scale bar represents the 
681 number of substitutions per amino acid position.
682 Figure 8. Co-expression of T1R2 and T1R3 in rabbit small intestine. A) A representative 
683 image shows expression of T1R2 (green), T1R3 (red) and merged image (yellow) in serial 
684 sections of rabbit small intestine as determined by double immunohistochemistry. B) A 
685 typical image showing expression of T1R2 or T1R3 (green), the enteroendocrine marker, 
686 chromogranin A (ChA, red) and merged image (yellow). Specificity of primary antibodies for 
687 T1R2 and T1R3 have been validated in mice.6 Omission of primary antibodies for T1R2 or 
688 T1R3 showed no non-specific immunoreactivity with secondary antibodies. (-T1R2 control 
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Trt effect P > 0.70
Time effect P < 0.001
Linear trend dose P > 0.30
SEM = 4.9g

















Trt effect P = 0.06
Time effect P < 0.001
Linear trend dose P > 0.40
SEM = 16.9g













Trt effect P > 0.50
Time effect P < 0.001
Linear trend dose P > 0.40
SEM = 0.05
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Trt effect P > 0.30
Time effect P < 0.001
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Trt effect P > 0.40
Time effect P < 0.001


























Trt effect P < 0.01
Time effect P < 0.001
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EEC – endocrine cell
AE AE AE AE AE AE AEAE AE AE
AE – absorptive enterocyte
Enteric neuron
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